These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 9864916

  • 21. [Allogeneic bone marrow transplantation in chronic myeloid leukemia. The clinical results and risk factors in 70 patients].
    Tomás JF, Peñarrubia MJ, García JA, Figuera A, Gómez-García de Soria V, Steegmann JL, Arranz R, Cámara R, Gabriel R, Vázquez L.
    Med Clin (Barc); 1995 Nov 11; 105(16):605-11. PubMed ID: 8523939
    [Abstract] [Full Text] [Related]

  • 22. Busulfan, cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation in children with myelodysplastic syndromes.
    Locatelli F, Pession A, Bonetti F, Maserati E, Prete L, Pedrazzoli P, Zecca M, Prete A, Paolucci P, Cazzola M.
    Leukemia; 1994 May 11; 8(5):844-9. PubMed ID: 8182940
    [Abstract] [Full Text] [Related]

  • 23. Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Mackinnon S, Barnett L, Heller G.
    Bone Marrow Transplant; 1996 Apr 11; 17(4):643-7. PubMed ID: 8722369
    [Abstract] [Full Text] [Related]

  • 24. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A, Iori A, Guglielmi C, Romano A, Cerretti R, Torromeo C, Micozzi A, Fenu S, Laurenti L, Donato V, De Felice L, Arcese W.
    Haematologica; 2002 Jan 11; 87(1):52-8. PubMed ID: 11801465
    [Abstract] [Full Text] [Related]

  • 25. Long term follow up after allogeneic stem cell transplantation for chronic myelogenous leukemia.
    Reiter E, Greinix HT, Brugger S, Keil F, Rabitsch W, Mannhalter C, Schwarzinger I, Höcker P, Fischer G, Dieckmann K, Hinterberger W, Linkesch W, Schneider B, Lechner K, Kalhs P.
    Bone Marrow Transplant; 1998 Dec 11; 22 Suppl 4():S86-8. PubMed ID: 9916646
    [Abstract] [Full Text] [Related]

  • 26. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
    Kröger N, Zabelina T, Sonnenberg S, Krüger W, Renges H, Stute N, Finkenstein F, Mayer U, Holstein K, Fiedler W, Colberg H, Sonnen R, Kuse R, Braumann D, Metzner B, del Valle F, Erttmann R, Kabisch H, Zander AR.
    Bone Marrow Transplant; 2000 Oct 11; 26(7):711-6. PubMed ID: 11042650
    [Abstract] [Full Text] [Related]

  • 27. Treatment of chronic myelogenous leukemia with allogeneic bone marrow transplantation after preparation with busulfan and cyclophosphamide (BuCy2): an update.
    Brodsky I, Biggs JC, Szer J, Crilley P, Atkinson K, Downs K, Dodds A, Concannon AJ, Avalos BR, Tutschka P.
    Semin Oncol; 1993 Aug 11; 20(4 Suppl 4):27-31; quiz 32. PubMed ID: 8342072
    [Abstract] [Full Text] [Related]

  • 28. Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Kröger N, Krüger W, Wacker-Backhaus G, Hegewisch-Becker S, Stockschläder M, Fuchs N, Rüssmann B, Renges H, Dürken M, Bielack S, de Wit M, Schuch G, Bartels H, Braumann D, Kuse R, Kabisch H, Erttmann R, Zander AR.
    Bone Marrow Transplant; 1998 Dec 11; 22(11):1029-33. PubMed ID: 9877263
    [Abstract] [Full Text] [Related]

  • 29. A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase.
    Elmaagacli AH, Runkel K, Steckel N, Opalka B, Trenschel R, Seeber S, Schaefer UW, Beelen DW.
    Bone Marrow Transplant; 2001 Apr 11; 27(8):809-15. PubMed ID: 11477437
    [Abstract] [Full Text] [Related]

  • 30. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
    Zander AR, Berger C, Kröger N, Stockshläder M, Krüger W, Horstmann M, Grimm J, Zeller W, Kabisch H, Erttmann R, Schönrock P, Kuse R, Braumann D, Illiger HJ, Fiedler W, de Witt M, Hossfeld KD, Weh HJ.
    Clin Cancer Res; 1997 Dec 11; 3(12 Pt 2):2671-5. PubMed ID: 10068272
    [Abstract] [Full Text] [Related]

  • 31. Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Runde V, de Witte T, Arnold R, Gratwohl A, Hermans J, van Biezen A, Niederwieser D, Labopin M, Walter-Noel MP, Bacigalupo A, Jacobsen N, Ljungman P, Carreras E, Kolb HJ, Aul C, Apperley J.
    Bone Marrow Transplant; 1998 Feb 11; 21(3):255-61. PubMed ID: 9489648
    [Abstract] [Full Text] [Related]

  • 32. [Treatment of chronic myeloid leukemia with bone marrow transplantation at the Institute of Hematology and Blood Transfusion in Prague].
    Hrabánek J, Lukásová M, Vítek A, Sajdová J, Jelínek J, Vanásek J, Chudomel V, Korínková P, Michalová K, Haskovec C.
    Vnitr Lek; 1995 Oct 11; 41(10):682-7. PubMed ID: 8578699
    [Abstract] [Full Text] [Related]

  • 33. Absence of influence of prior treatment with interferon on the outcome of allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Tomás JF, López-Lorenzo JL, Requena MJ, Aguilar R, Steegmann JL, Cámara R, Alegre A, Arranz R, Figuera A, Fernández-Rañada JM.
    Bone Marrow Transplant; 1998 Jul 11; 22(1):47-51. PubMed ID: 9678795
    [Abstract] [Full Text] [Related]

  • 34. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
    Hambach L, Eder M, Dammann E, Battmer K, Stucki A, Heil G, Ganser A, Hertenstein B.
    Bone Marrow Transplant; 2001 Oct 11; 28(7):705-7. PubMed ID: 11704795
    [Abstract] [Full Text] [Related]

  • 35. Role of pretransplant interferon-alpha(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): results from three Turkish transplant centers.
    Beksac M, Celebi H, Sargín D, Yalcin A, Topcuoglu P, Kalayoglu-Besisik S, Beyan C, Arslan O, Ozcan M, Gurman G, Ilhan O, Akan H.
    Bone Marrow Transplant; 2003 May 11; 31(10):897-904. PubMed ID: 12748666
    [Abstract] [Full Text] [Related]

  • 36. [Results of treatment of children with chronic myelogenous leukaemia (CML) obtained by the Polish Paediatric Leukaemia/Lymphoma Study Group].
    Chybicka A, Kałwak K, Bogusławska-Jaworska J, Turkiewicz D, Armata J, Balcerska A, Bubała H, Boruczkowski D, Cwiklińska M, Hicke A, Kaczmarek-Kanold M, Kolecki P, Kowalczyk J, Krauze A, Matysiak M, Płoszyńska A, Rokicka-Milewska R, Sońta-Jakimczyk D, Sikorska-Fic B, Staszak-Kowalska R, Tomaszewska R, Wiśniewska-Slusarz H, Wachowiak J, Wysocki M, Polish Paediatric Leukaemia/Lymphoma Study Group.
    Med Wieku Rozwoj; 2000 May 11; 4(1 Suppl 2):49-55. PubMed ID: 12021462
    [Abstract] [Full Text] [Related]

  • 37. Late mortality and relapse following BuCy2 and HLA-identical sibling marrow transplantation for chronic myelogenous leukemia.
    Copelan EA, Crilley PA, Szer J, Dodds AJ, Stevenson D, Phillips G, Elder P, Nivison-Smith I, Avalos BR, Penza S, Topolsky D, Sobecks R, Kalaycio M, Bolwell BJ.
    Biol Blood Marrow Transplant; 2009 Jul 11; 15(7):851-5. PubMed ID: 19539217
    [Abstract] [Full Text] [Related]

  • 38. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
    Liu QF, Sun J, Zhang Y, Liu XL, Xu D, Xu B, Feng R, Meng FY, Zhou SY.
    Ai Zheng; 2004 Apr 11; 23(4):426-9. PubMed ID: 15087032
    [Abstract] [Full Text] [Related]

  • 39. [Treatment results of bone marrow transplantation in Kyushu Cancer Center. Bone Marrow Transplantation Team].
    Tasaka H, Ikuno Y, Okamura J.
    Rinsho Ketsueki; 1990 Mar 11; 31(3):315-9. PubMed ID: 2366334
    [Abstract] [Full Text] [Related]

  • 40. Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology.
    Aladjidi N, Auvrignon A, Leblanc T, Perel Y, Bénard A, Bordigoni P, Gandemer V, Thuret I, Dalle JH, Piguet C, Pautard B, Baruchel A, Leverger G, French Society of Pediatric Hematology and Immunology.
    J Clin Oncol; 2003 Dec 01; 21(23):4377-85. PubMed ID: 14645428
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.